During the past decade, Pat Moore conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pat Moore" #1 collaborator was "Edwards Lifesciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pat Moore" are "Heart Failure" (1 trials) and "Hemodynamic Monitoring" (1 trials). Many other conditions were trialed in "Pat Moore" in a lesser frequency.

Most popular intervention types in "Pat Moore" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "No Hemodynamic Monitored Guided Assesment" (1 trials), "Observational Study to Evaluate Utility of Non-invasive Hemodynamic Monitoring" (1 trials) and "invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pat Moore" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pat Moore". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Pat Moore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pat Moore, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".